Emerging Technologies in Pharma & AI Summit 2025
Vienna, Austria
December 03-04, 2025
Join us at the Emerging Technologies in Pharma & AI Summit 2025 in Vienna, with physical, online, and hybrid attendance options. Dr. Ewa Gajewska will deliver our keynote.
It’s a first‑edition, two‑day program focused on how AI is transforming pharma—covering AI in drug discovery, machine learning in clinical trials, generative AI, digital twins, AI‑driven pharmacovigilance, ethical AI, and the regulatory outlook. Speakers include leaders from organizations such as Merck KGaA, Darmstadt, Germany, BMS, Pfizer, Novo Nordisk, Lundbeck, and Abbott, sharing real‑world use cases and strategies.
- Learn: Get concise, practical insights on AI across the pharma lifecycle—from discovery to safety and compliance.
- Benchmark: Compare your AI initiatives with peers and hear what worked (and what didn’t) in case‑driven sessions.
- Network: Engage with senior decision‑makers and experts in interactive roundtables and discussions.
Speaker
Dr. Ewa Gajewska holds a position of a Head of Product Management in Merck, Darmstadt, Germany where she leads the development of SYNTHIA® Retrosynthesis Software. She graduated in biotechnology and chemistry from the Gdansk University of Technology and was a recipient of the Outstanding Achievements Award from Poland’s Minister of Science and Higher Education. In 2020 she received her PhD from the Institute of Organic Chemistry at the Polish Academy of Sciences. Her doctoral work was devoted to development of the SYNTHIA® Retrosynthesis Software for computer-assisted synthetic planning. Her passion for tackling complex scientific challenges within commercial settings and the unique blend of her interdisciplinary skills drive the realization of innovative features of SYNTHIA® Retrosynthesis Software.
